Sinobiomed Inc. (SOBM.OB): Chinese Wonder Drug-Maker?
Source: http://Blog.QualityStocks.net/?p=12185Posted on Friday, September 5th, 2008 | In Small & Micro Cap
Sinobiomed (SOBM) is a Chinese developer of genetically engineered recombinant protein drugs and vaccines. The company’s drugs treat diseases and ailments such as malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration. Sinobiomed currently has 10 products: three on the market, four in clinical trials and three in research and development.
Sinobiomed, based in the bustling metropolis of Shanghai, could be on the forefront of the burgeoning Chinese biotechnology industry. China’s biotech industry is expected to continue its rapid expansion of 20 percent to 30 percent annually to $8.5 billion by 2010 helped by government contributions of $600 million annually. The Chinese pharmaceutical industry is expected to be the world’s 5th largest market by 2010.
Sinobiomed is considered a market leader in the area of recombinant protein drugs and recently acquired a distributor to facilitate a more expeditious sale of some its drugs. The company has one of China’s largest capacities for the manufacturing of recombinant bioproducts at an extremely low cost and its international alliances give the firm global advantages.
Sinobiomed also has a cosmetics and skin care business that is expected to generate sales of $3 million in the next year with profit margins of over 70 percent. The company is in talks with home shopping TV channels in China, India and other emerging markets to feature its skin care products.
The company said in August it received a $500,000 cash injection from Asian investment fund Accelera Ventures. Sinobiomed had total expenses of $1.8 million for the first three months of this year. Shares closed at 43 cents on Friday and have traded between 21 cents and $3.04 in the past 52 weeks.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Lion Energy, Southern Star Energy (SSEY.OB), Gold Star Resources Fuse to Create Combined Company with Promising Growth Opportunities - November 6th, 2009
- VIASPACE, Inc. (VSPC.OB) Subsidiary Ionfinity Captivates Mass Spectrometry Market - November 6th, 2009
- Google’s Android Takes a Bite Out of Apple - November 6th, 2009
- Continucare Corp. (CNU) First Quarter Fiscal Year 2010 Results Show 116% Increase in Operating Profit - November 6th, 2009
- Muscle Flex, Inc. (MFLI.PK) Now Accepting Orders for the Beagle StepFit, the BUDDY Tablet Caddy and “Danny Alex Commercial Blue” T-Shirts - November 6th, 2009
Accelera Ventures, Biotechnology, biotechnology industry, cancer, cents, China, hepatitis, India, Malaria, Pharmaceutical Industry, Rheumatoid Arthritis, shanghai, Sinobiomed Inc., skin care products, Small & Micro Cap, USD, Vaccines
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |



